Stocksigma LogoStocksigma Logo

Biofil Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 167 (-87.7% YoY | -86.5% QoQ) ■ EBITDA: 10.3 (-10.4% YoY | -27.1% QoQ) ■ EBITDA Margin (%): 6.1 (+530 bps YoY | +500 bps QoQ) ■ PAT: 11.5

Biofil Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26

Biofil Chemicals & Pharmaceuticals Ltd · Outcome · 15 Nov 2026, 12:16 am

Biofil Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 167 (-87.7% YoY | -86.5% QoQ) ■ EBITDA: 10.3 (-10.4% YoY | -27.1% QoQ) ■ EBITDA Margin (%): 6.1 (+530 bps YoY | +500 bps QoQ) ■ PAT: 11.5 (+37.9% YoY | +5.7% QoQ) ■ EPS (INR): 0.07 (+40.0% YoY | +0.0% QoQ) Biofil Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) Segmental Performance Pharma Unit ■ Revenue: 167 (-86.3% YoY | -46.8% QoQ) ■ EBIT: 1.3 (-82.5% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 0.8 (+16 bps YoY | Loss to Profit QoQ) Chemicals Division ■ Revenue: 0.0 (-100.0% YoY | -100.0% QoQ) ■ EBIT: 10.2 (+2123.9% YoY | -33.7% QoQ) ■ EBIT Margin (%): 0.0 (-33 bps YoY | -167 bps QoQ)

Original exchange filing (PDF)

More announcements from Biofil Chemicals & Pharmaceuticals Ltd

All Biofil Chemicals & Pharmaceuticals Ltd announcements